Welcome to our dedicated page for JBT Marel Corporation news (Ticker: JBTM), a resource for investors and traders seeking the latest updates and insights on JBT Marel Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect JBT Marel Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of JBT Marel Corporation's position in the market.
JBT Marel (NYSE and Nasdaq Iceland: JBTM) announced the completion of JBT 's voluntary takeover of Marel hf. The combined company began trading under the ticker 'JBTM' on both NYSE and Nasdaq Iceland. Brian Deck will serve as CEO and Árni Sigurdsson as President of JBT Marel.
The company has initiated a compulsory acquisition of remaining Marel shares, expected to complete in February 2025. Marel shares will be delisted from Euronext Amsterdam and Nasdaq Iceland, with the last trading day being January 3, 2025. The company plans to report standalone JBT financial results for Q4 and full-year 2024 in late February 2025, along with providing an update on combined company financials and 2025 outlook.
FAQ
What is the current stock price of JBT Marel Corporation (JBTM)?
What is the market cap of JBT Marel Corporation (JBTM)?
